These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32986750)

  • 21. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
    Barneh F; Jafari M; Mirzaie M
    Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
    Nandi S; Chauhan B; Tarannum H; Khede MK
    Curr Top Med Chem; 2023; 23(5):403-414. PubMed ID: 36694313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PubChem as a source of polypharmacology.
    Chen B; Wild D; Guha R
    J Chem Inf Model; 2009 Sep; 49(9):2044-55. PubMed ID: 19708682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Web-Based Tools for Polypharmacology Prediction.
    Awale M; Reymond JL
    Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docking Studies for Multi-Target Drugs.
    Scotti L; Mendonca Junior FJ; Ishiki HM; Ribeiro FF; Singla RK; Barbosa Filho JM; Da Silva MS; Scotti MT
    Curr Drug Targets; 2017; 18(5):592-604. PubMed ID: 26302806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.
    Caesar LK; Cech NB
    Nat Prod Rep; 2019 Jun; 36(6):869-888. PubMed ID: 31187844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic polypharmacology: A new frontier for epi-drug discovery.
    Tomaselli D; Lucidi A; Rotili D; Mai A
    Med Res Rev; 2020 Jan; 40(1):190-244. PubMed ID: 31218726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view.
    Engin HB; Gursoy A; Nussinov R; Keskin O
    Curr Pharm Des; 2014; 20(8):1201-7. PubMed ID: 23713773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer?
    Bonam SR; Wu YS; Tunki L; Chellian R; Halmuthur MSK; Muller S; Pandy V
    ChemMedChem; 2018 Sep; 13(18):1854-1872. PubMed ID: 29927521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Docking: Shifting Paradigms in Drug Discovery.
    Pinzi L; Rastelli G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terpene core in selected aromatic and edible plants: Natural health improving agents.
    Petrović J; Stojković D; Soković M
    Adv Food Nutr Res; 2019; 90():423-451. PubMed ID: 31445600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacology - foe or friend?
    Peters JU
    J Med Chem; 2013 Nov; 56(22):8955-71. PubMed ID: 23919353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polypharmacology Shakes Hands with Complex Aetiopathology.
    Brodie JS; Di Marzo V; Guy GW
    Trends Pharmacol Sci; 2015 Dec; 36(12):802-821. PubMed ID: 26434643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
    Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
    Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of orthologous target pairs with shared active compounds and comparison of organism-specific activity patterns.
    Dimova D; Stumpfe D; Bajorath J
    Chem Biol Drug Des; 2015 Nov; 86(5):1105-14. PubMed ID: 25931211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the mode of action of bioactive compounds.
    Azad MA; Wright GD
    Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational tools for polypharmacology and repurposing.
    Achenbach J; Tiikkainen P; Franke L; Proschak E
    Future Med Chem; 2011 Jun; 3(8):961-8. PubMed ID: 21707399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual or multi-targeting inhibitors: The next generation anticancer agents.
    Raghavendra NM; Pingili D; Kadasi S; Mettu A; Prasad SVUM
    Eur J Med Chem; 2018 Jan; 143():1277-1300. PubMed ID: 29126724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.